FULGENT GENETICS, INC. Operating Lease, Lease Income
FULGENT GENETICS, INC. (FLGT) reported Operating Lease, Lease Income of $17.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseLeaseIncome · last filed 2024-05-03
- FULGENT GENETICS, INC. operating lease, lease income for the quarter ending 2024-03-31 was $17.00K, a 62.22% decline year-over-year.
- FULGENT GENETICS, INC. operating lease, lease income for the quarter ending 2023-12-31 was $37.00K, a 7.50% decline year-over-year.
- FULGENT GENETICS, INC. operating lease, lease income for the quarter ending 2023-09-30 was $37.00K, a 22.92% decline year-over-year.
- FULGENT GENETICS, INC. operating lease, lease income for the quarter ending 2023-06-30 was $45.00K, a 52.63% decline year-over-year.
- FULGENT GENETICS, INC. operating lease, lease income for fiscal 2023 was $164.00K, a 41.64% decline from fiscal 2022.
- FULGENT GENETICS, INC. operating lease, lease income for fiscal 2022 was $281.00K, a 33.10% decline from fiscal 2021.
- FULGENT GENETICS, INC. operating lease, lease income for fiscal 2021 was $420.00K, a 189.66% increase from fiscal 2020.
- FULGENT GENETICS, INC. operating lease, lease income for fiscal 2020 was $145.00K.
| Period end | Operating Lease, Lease Income 3 month | Operating Lease, Lease Income 6 month | Operating Lease, Lease Income 9 month | Operating Lease, Lease Income 12 month |
|---|---|---|---|---|
| 2024-03-31 | $17.00K 10-Q · filed 2024-05-03 | $54.00K derived: sum of 2 quarters · filed 2024-05-03 | $91.00K derived: sum of 3 quarters · filed 2024-05-03 | $136.00K derived: sum of 4 quarters · filed 2024-05-03 |
| 2023-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $74.00K derived: sum of 2 quarters · filed 2024-02-28 | $119.00K derived: sum of 3 quarters · filed 2024-02-28 | $164.00K 10-K · filed 2024-02-28 |
| 2023-09-30 | $37.00K 10-Q · filed 2023-11-03 | $82.00K derived: sum of 2 quarters · filed 2023-11-03 | $127.00K 10-Q · filed 2023-11-03 | $167.00K derived: sum of 4 quarters · filed 2024-05-03 |
| 2023-06-30 | $45.00K 10-Q · filed 2023-08-04 | $90.00K 10-Q · filed 2023-08-04 | $130.00K derived: sum of 3 quarters · filed 2024-05-03 | $178.00K derived: sum of 4 quarters · filed 2024-05-03 |
| 2023-03-31 | $45.00K 10-Q · filed 2024-05-03 | $85.00K derived: sum of 2 quarters · filed 2024-05-03 | $133.00K derived: sum of 3 quarters · filed 2024-05-03 | $228.00K derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $88.00K derived: sum of 2 quarters · filed 2024-02-28 | $183.00K derived: sum of 3 quarters · filed 2024-02-28 | $281.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $48.00K 10-Q · filed 2023-11-03 | $143.00K derived: sum of 2 quarters · filed 2023-11-03 | $241.00K 10-Q · filed 2023-11-03 | $340.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $95.00K 10-Q · filed 2023-08-04 | $193.00K 10-Q · filed 2023-08-04 | $292.00K derived: sum of 3 quarters · filed 2024-02-28 | $371.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $98.00K 10-Q · filed 2023-05-05 | $197.00K derived: sum of 2 quarters · filed 2024-02-28 | $276.00K derived: sum of 3 quarters · filed 2024-02-28 | $361.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $99.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $178.00K derived: sum of 2 quarters · filed 2024-02-28 | $263.00K derived: sum of 3 quarters · filed 2024-02-28 | $420.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | $79.00K 10-Q · filed 2022-11-07 | $164.00K derived: sum of 2 quarters · filed 2022-11-07 | $321.00K 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $85.00K 10-Q · filed 2022-08-04 | $242.00K 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $157.00K 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $145.00K 10-K · filed 2023-02-28 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |